At NUVISAN, we have a unique 3 million compound library (REF 1, 2) and more than a billion associated experimental data points that cover biological activity on a wide range of target classes, physchem, ADMET end points, and more. By leveraging the legacy data, we provide informed decisions through data mining and custom predictive tools for various stages of the drug discovery pipeline.
During all stages of a drug discovery process, using the information in the LSDB, we can provide the following:
In addition, we offer custom services to curate and annotate your project data, ensuring a smooth transition of your project to NUVISAN. We use state-of-the-art tools and platforms for handling chemical structures and associated biological activity data to get maximum insight from them. NUVISAN offers data services with an aim of reducing the cost and time needed in each stage of drug development. Get in touch to learn more about our data services and how we can help your company accelerate the drug development process.